SherpaBonds
US78081BAR42 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 5.40% 2034/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
102.32
par = 100
YIELD TO MAT.
5.20%
semi-annual
COUPON
5.400%
semi-annual · fixed
MATURITY
2034-09-02
bullet · 8.32y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
6.59 y
1bp ↑ ≈ -0.066% P&L
Convexity
52.70
higher = more curvature
Years to maturity
8.32 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Total Bond Market
Vanguard
US Aggregate$8.5M—0.00%2026-03-31
iShares 5-10 Year Investment Grade Corporate Bond
iShares
US IG Corporate$3.7M▼ $46K0.02%2026-05-07
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$2.9M▼ $11K0.00%2026-05-07
Vanguard Intermediate-Term Bond
Vanguard
US Aggregate Intermediate$2.0M—0.00%2026-03-31
iShares iBonds Dec 2034 Term Corporate
iShares
iBonds 2034 Corporate$1.3M▼ $5K0.16%2026-05-07
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$1.2M▲ $3K0.01%2026-05-05
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.1M▼ $4K0.01%2026-05-07
iShares Core Universal USD Bond
iShares
US Aggregate$619K▼ $2K0.00%2026-05-07
SPDR Portfolio Aggregate Bond
SPDR
US Aggregate$506K▲ $1K0.01%2026-05-05
Vanguard Intermediate-Term Corporate Bond
Vanguard
US Corporate Intermediate$368K—0.00%2026-03-31
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$179K▼ $7040.00%2026-05-07
SPDR Portfolio Corporate Bond
SPDR
US IG Corporate$112K▲ $2940.01%2026-05-05
iShares ESG Aware USD Corporate Bond
iShares
US ESG IG Corporate$67K▼ $2610.00%2026-05-07
iShares ESG Aware U.S. Aggregate Bond
iShares
US ESG Aggregate$61K▼ $2410.00%2026-05-07
iShares Core 5-10 Year USD Bond
iShares
US Aggregate$5K▼ $200.00%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$105—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

62/ 100Broad ownership
Interpretation. Moderate institutional footprint, with net accumulation
HOLDERS
16
▲ 2 signals in 7d
AGGREGATE EXPOSURE
$22.5M
USD across all
TOP CONCENTRATION
37.9%
largest holder
FLOW
▲ $2.8M
▲ 2 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
102,320 USD
PRICE
102.32

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 5.4 09/02/34
FIGI
BBG01N5DKR11
CUSIP
78081BAR4
ISIN
US78081BAR42
Type
Corp
Issued
2024-06-10
Face value
100 USD
Ticker
RPRX 5.4 09/02/34
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+8 bps yield+1y duration8 signals in commonSame issuer
Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.79%
−41 bps yield−3y duration7 signals in commonSame issuer
Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.73%
−47 bps yield−3y duration6 signals in commonSame issuer
Royalty Pharma Plc 2.2% 09/2030
Royalty Pharma Plc
2030-09
4.68%
−52 bps yield−4y duration5 signals in commonSame issuer
Royalty Pharma Plc 5.15% 09/2029
Royalty Pharma Plc
2029-09
4.60%
−60 bps yield−5y duration5 signals in commonSame issuer
Royalty Pharma Plc 5.9% 09/2054
Royalty Pharma Plc
2054-09
6.01%
+81 bps yield+20y duration6 signals in commonSame issuer